Helus Pharma Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
8.96
+0.57 (6.79%)
At close: Nov 6, 2026, 4:00 PM EST
9.11
+0.14 (1.62%)
After-hours: Nov 6, 2026, 7:45 PM EST
Helus Pharma Market Cap
Helus Pharma has a market cap or net worth of $654.62 million as of November 6, 2026. It is the 12,546th most valuable company in the world and the 2,523rd biggest in the United States. Its market cap has increased by 120.46% in one year.
Market Cap
654.62M
Enterprise Value
488.25M
1-Year Change
120.46%
Global Rank
Country Rank
#2,523 United States
Category
ChartMarket Cap Chart
Since November 11, 2020, Helus Pharma's market cap has increased from $91.08M to $654.62M, an increase of 618.72%. That is a compound annual growth rate of 39.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 654.62M | 60.36% |
| Dec 31, 2025 | 408.21M | 131.40% |
| Dec 31, 2024 | 176.41M | 4.63% |
| Dec 29, 2023 | 168.60M | 199.71% |
| Dec 30, 2022 | 56.25M | -72.57% |
| Dec 31, 2021 | 205.10M | 4.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aura Biosciences | 680.30M |
| 4D Molecular Therapeutics | 676.74M |
| ArriVent BioPharma | 672.56M |
| Candel Therapeutics | 669.54M |
| Immix Biopharma | 668.20M |
| Wave Life Sciences | 663.68M |
| Adlai Nortye Group | 662.01M |
| Design Therapeutics | 653.81M |